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Studies have characterized Trypanosoma cruzi from 
parasite-endemic regions. With new human cases, increas-
ing numbers of veterinary cases, and inﬂ  ux of potentially 
infected immigrants, understanding the ecology of this or-
ganism in the United States is imperative. We used a clas-
sic typing scheme to determine the lineage of 107 isolates 
from various hosts.
I
n Latin America, an estimated 10–12 million persons 
are infected with Trypanosoma cruzi, the etiologic agent 
of Chagas disease and a major contributor to heart disease 
within the region. Autochthonous human infections in the 
United States have been reported in 6 persons, with the 
most recent case reported from Louisiana (1). In addition, 
the parasite is euryxenous; it is able to infect a broad range 
of hosts, including domestic dogs, woodrats, raccoons, 
opossums, armadillos, and nonhuman primates.
Associations between host species and parasite geno-
type have been suggested and are important in understand-
ing the domestic and sylvatic cycles of T.  cruzi ( 2–4). 
Although studies conducted on US isolates suggest an as-
sociation between T. cruzi genotype and host, these studies 
were limited because of low sample numbers, low host di-
versity, and narrow geographic distribution (2,4–7). In the 
current investigation, we used the molecular typing scheme 
proposed by Brisse et al. (8), in which isolates are delin-
eated into 1 of the 6 lineages (types I and IIa–IIe) on the 
basis of size polymorphisms of several PCR markers. We 
then expanded characterization of US isolates and show ad-
ditional evidence for correlations between host speciﬁ  city 
and genotype of T. cruzi.
The Study
We analyzed 107 isolates of T. cruzi from multiple 
species of free-ranging and captive wildlife, domestic ani-
mals, triatomine bug vectors, and humans who were au-
tochthonously infected in the United States. Some isolates 
were obtained as liquid nitrogen–stored parasites from the 
Centers for Disease Control and Prevention (Atlanta, GA, 
USA), the Institut Pasteur (Paris, France), and the South-
eastern Cooperative Wildlife Disease Study (Athens, GA, 
USA) and were established in axenic liver infusion tryptose 
medium as described (9). Additional isolates were obtained 
from wild-trapped animals in axenic liver infusion tryptose 
medium or canine macrophage cell culture as described 
(10). Isolated DNA was used as template for PCR ampliﬁ  -
cation of 3 gene targets, mini-exon, D7 divergent domain 
of 24S α rRNA, and 18S rRNA, according to published 
methods (8). Locality data and results of molecular typ-
ing of each isolate are shown in the online Appendix Table 
(available from www.cdc.gov/EID/content/14/7/1123-
appT.htm). All animals used in this study were cared for in 
accordance with the guidelines of the Institutional Animal 
Care and Use Committee and under animal use protocol 
approved by the Institutional Animal Care and Use Com-
mittee at the University of Georgia.
Only 2 genotypes, T. cruzi I and T. cruzi IIa, were de-
tected. Typical amplicon sizes of T. cruzi I and T. cruzi 
IIa isolates from the United States are shown in the Table. 
Atypical banding patterns and isolates that differ from the 
standard genotype from a particular host are also represent-
ed. With the exception of human isolates, 1 primate isolate, 
and a few raccoon isolates, placental mammalian isolates, 
including those from raccoons, domestic dogs, ring-tailed 
lemurs, and skunks, were characterized as type IIa (online 
Appendix Table). All remaining isolates, including those 
from Virginia opossums (Didelphis virginiana), triatom-
ine vectors, humans, and rhesus macaques from the United 
States, were identiﬁ  ed as type I (online Appendix Table).
Conclusions
In contrast to studies conducted on South American 
isolates, for which 6 genotypes of T. cruzi have been iden-
tiﬁ  ed, only 2 genotypes (I and IIa) were identiﬁ  ed in the 
current study. These data support results of investigations 
in Central America and Mexico in which a paucity of geno-
types was found (14,15). Many investigations on T. cruzi 
evolutionary ecology have shown strict host–parasite spec-
iﬁ  city in regard to host species and parasite genotype (2–4), 
although exceptions have been observed. The presence of 
only 2 genotypes in the United States could be caused by 
a lack of introduction of other genotypes or a lower diver-
sity of natural reservoir hosts for T. cruzi than in South 
America. A recent analysis of T. cruzi hosts in North and 
South America indicated that >48 host species representing 
17 families were infected with >1 of the 6 strains (4). Only 
6 of these hosts have established populations in the United 
States, and US isolates from these species were only char-
acterized as types I or IIa (4).
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vious studies in which Didelphis spp. are reservoirs for 
type I T. cruzi (4); no infections with type II parasites were 
observed. The Virginia opossum (and its ancestors), which 
is the only marsupial present in the United States (it mi-
grated from South America ≈4.5 million years ago), is a 
possible host for T. cruzi I. This evidence suggests that T. 
cruzi was not recently introduced into North America or the 
United States (5). Additionally, sufﬁ  cient time may have 
passed for random and rare genetic exchange events to oc-
cur independent of those found in South American isolates 
(13), enabling the lineage to infect atypical reservoirs (i.e., 
raccoons) in North America.
The second major natural reservoir of T. cruzi in the 
United States is the raccoon. In general, the nonprimate 
placental mammals in our study were infected with type 
IIa, a strain that is commonly found in sylvatic cycles in the 
Southern Cone of South America. Our data conﬁ  rm previ-
ous typing of US isolates by multilocus enzyme electro-
phoresis or random ampliﬁ  ed polymorphic DNA analysis 
(5), in which 11 raccoons from Georgia were characterized 
as zymodeme 3 (equivalent to IIa). Although raccoons are 
predominately infected with T. cruzi IIa, 4 known excep-
tions include 3 isolates from Georgia and Florida in the 
current study and 1 raccoon from Louisiana from a previ-
ous study (5).These data are in contrast to typing data for 
Virginia opossum isolates, which have all found T. cruzi 
I. This ﬁ  nding suggests that opossums primarily maintain 
persistent infections with T. cruzi I.
All characterized human isolates from autochthonous 
US cases of infection with T. cruzi are T. cruzi I. This 
genotype is predominantly responsible for Chagas disease 
north of the Amazon Basin and is part of the domiciliary 
cycle of the parasite. Our ﬁ  ndings correspond with data 
from Mexico where T. cruzi I is the predominate strain de-
tected in humans (14). It would be useful to differentiate 
biologic characteristics and polymorphisms by using addi-
tional gene targets in human type I isolates and compare 
them with those in opossum, triatomine vectors, and rhe-
sus macaque isolates from the United States. Additionally, 
comparing these US isolates and Mexican reference strains 
with those from South America may indicate why type I 
typically infects humans in North America and multiple 
strains are found in humans in South America.
Our results provide additional evidence that T. cruzi 
has distinct genotypes that preferentially infect 1 host spe-
cies or a group of hosts. Humans and marsupials are typi-
cally infected with type I T. cruzi, but raccoons, skunks, 
domestic dogs, and prosimians are typically infected with 
type IIa. Although we only detected T. cruzi I in triatomid 
bugs, other studies have detected T. cruzi IIa in triatomids 
from the United States (5). The mechanism is unknown by 
which persistent infections with a particular genotype of 
T. cruzi develop in certain hosts. Further analysis of iso-
lates from an increased host diversity and geographic range 
should be pursued. Determining basic infection dynamics 
of reservoir hosts experimentally infected with various T. 
cruzi genotypes may provide additional insight into the 
host–parasite dichotomy.
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